Healwell AI Inc. - MCIOF STOCK NEWS

Welcome to our dedicated page for Healwell AI news (Ticker: MCIOF), a resource for investors and traders seeking the latest updates and insights on Healwell AI stock.

HEALWELL AI Inc. (MCIOF) is a health care technology company that focuses on AI and data science for preventive care. The company's mission is to enhance healthcare and save lives through early identification and detection of diseases. As a physician-led organization with an experienced management team, HEALWELL AI is dedicated to developing and acquiring technology and clinical sciences capabilities to advance its roadmap. Publicly traded on the Toronto Stock Exchange under the symbol AIDX, HEALWELL AI is at the forefront of leveraging AI and data science for the benefit of patients and healthcare providers.

10/18/2023 08:00 AM

News

WELL Health Launches 'WELL AI Decision Support' Powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems

Rhea-AI Summary

WELL Health Technologies and HEALWELL AI announce the launch of WELL AI Decision Support, a new service for healthcare providers. The partnership aims to improve early disease diagnosis and preventative health. WELL Health has invested $18 million in HEALWELL AI and is now the largest equity shareholder. The launch of WELL AI Decision Support aligns with WELL's strategy to empower healthcare providers with transformative technology.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the market cap of Healwell AI (MCIOF)?

The market cap of Healwell AI (MCIOF) is approximately 52.3M.

What is HEALWELL AI Inc. focused on?

HEALWELL AI is a health care technology company that focuses on AI and data science for preventive care.

What is the mission of HEALWELL AI Inc.?

HEALWELL AI's mission is to improve health care and save lives through early identification and detection of disease.

How is HEALWELL AI Inc. described?

HEALWELL AI is a physician-led organization with a proven management team, dedicated to developing and acquiring technology and clinical sciences capabilities.